IP Library Granted Patent US 8,822,231
Granted Patent B2
US 8,822,231 · App. 12/988,162 · Granted Sep 2, 2014

Assay method and device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,822,231
App. No.
12/988,162
Granted
Sep 2, 2014
Kind
B2
Abstract

A method for the analysis of at least two analytes in a liquid sample, in which a substrate is provided wherein at least two different types of capturing molecules are immobilized on the substrate and wherein each type of capturing molecule has specific affinity for an analyte. The sample is contacted with capturing molecules, wherein for at least one analyte to be analyzed contact is induced between the capturing molecules and a labelled detection molecule with specific affinity for the analyte, and for at least one another analyte to be contact is induced between the capturing molecules and a labelled version of the analyte. A detectable signal is measured from the labelled detection molecule and the labelled analyte on the substrate, wherein the concentration of the labelled analyte is adapted to the concentration of the analyte in the sample.

Claims (18)

1. A method for analysis of at least two analytes in a liquid sample, including a first analyte expected to be in a first concentration and a second analyte expected to be in a second concentration that is much higher than the first concentration, said method comprising the steps of:

providing an analysis device comprising a substrate wherein at least two different types of capturing molecules are immobilized on the substrate in separately distinct areas and wherein each type of capturing molecule has specific affinity for the first and second analytes, respectively,

contacting the liquid sample with said immobilized capturing molecules,

for the first analyte to be analyzed and expected to have the first concentration: adding at least one type of labeled detection molecule having a specific affinity for the first analyte to be analyzed and inducing contact between the first analyte which is bound to or will be bound to the capturing molecules and the at least one added labelled detection molecule, and

for the second analyte to be analyzed and expected to have the second concentration: adding a labeled version or a labeled fragment of the second analyte and inducing contact between the capturing molecules , the second analyte, and the labelled version of the second analyte, and

measuring a detectable signal from each of: i) labelled detection molecules, which detection molecules are bound to the first analyte, which first analyte are bound to capturing molecules, which capturing molecules are bound to the substrate and in which the detectable signal increases with an increasing concentration of the first analyte, and ii) the labelled second analyte on the substrate in which the detectable signal decreases with an increasing concentration of the second analyte to be analyzed, wherein the concentration of the labelled analyte is adapted to the concentration of the unlabelled analyte in the liquid sample.

2. The method according to claim 1 , wherein each of said capturing molecules independently is selected from the group consisting of an antibody, an aptamer, a nucleic acid probe, a DNA probe, a RNA probe, a PNA probe, an antibody fragment, a Fab fragment, and a scFv fragment.

3. The method according to claim 1 , wherein said capturing molecules are antibodies.

4. The method according to claim 1 , wherein said detection molecule is at least one molecule selected from an antibody, an antibody fragment, a Fab fragment, a scFv fragment, an aptamer, a nucleic acid probe, a DNA probe, a RNA probe, and a PNA probe.

5. The method according to claim 1 , wherein said detection molecules are antibodies.

6. The method according to claim 1 , wherein said contact between the capturing molecules and a labelled detection molecule is induced by adding a labelled detection molecule to the device.

7. The method according to claim 1 , wherein said contact between the capturing molecules and a labelled detection molecule is induced by dissolution of a pre dispensed substance on the device.

8. The method according to claim 1 , wherein said contact between the capturing molecules and a labelled analyte is induced by adding a labelled analyte to the device.

9. The method according to claim 1 , wherein said contact between the capturing molecules and a labelled analyte is induced by the steps of first adding a labelled analyte to the sample and then contacting the sample with the capturing molecules.

10. The method according to claim 1 , wherein said contact between the capturing molecules and a labelled analyte is induced by dissolution of a pre dispensed substance on the device.

11. The method according to claim 1 , wherein the sample is contacted with the capturing molecules for a period of time sufficiently long to reach equilibrium for the binding of analyte molecules to the capturing molecules.

12. The method according to claim 1 , wherein said substrate at least partly includes a plurality of projections substantially vertical to a support surface, said projections having a height (H1), diameter (D1) and reciprocal spacing (x1,y1) such, that lateral capillary flow of said liquid sample is achieved.

13. The method according to claim 1 , wherein said substrate comprises at least one sample addition zone, at least one receiving zone with the capacity to receive at least a part of the sample and at least one connecting zone establishing a fluid connection between the sample addition zone and the at least one receiving zone.

Assignments (8)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2018
From: JOHNSON & JOHNSON AB
To: CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 046773/0588 →
MERGER Recorded Jul 24, 2014
From: AMIC AB
To: JOHNSON & JOHNSON AB
Reel/Frame 033385/0464 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2010
From: MELIN, JONAS; JONSSON, CHRISTINA
To: AMIC AB
Reel/Frame 025529/0473 →